APOB and metabolic syndrome: While it is well-recognized that non-HDL-C and apoB are closely related metabolically, yet there is ongoing discussion as to whether one should be measured preferentially over the other, with some considering apoB as a choice proatherogenic index in patients with cardiometabolic risk associated with atherogenic dyslipidemia.